Current FDA drug shortages

What "current" means here

A current shortage is one the FDA records as active — that is, the supply of the product is recorded as not meeting demand at the time of the source data. These are the entries with the most immediate operational relevance, because they describe supply constraints that may still be in effect. On this page the status is taken directly from the FDA's public shortage data and normalised to the single value "current"; we do not infer activity that the source does not state.

Because current shortages are by definition the most time-sensitive entries, the caution about data currency matters most here. The list reflects the state of the data at the most recent ingestion run, and the live FDA record can change between runs as shortages are updated or resolved. Always confirm the current status against the official FDA source before relying on it for any planning decision, and treat this page strictly as a pointer to that authoritative record.

Current shortage records

The active shortage records in the indexed dataset are listed below, most recently updated first. Each links to its own record page, which lays out the product, company, presentation, availability text and dates as regulatory data fields and links onward to the official FDA source.

Why current shortages matter operationally

Current shortages are the entries with the most direct bearing on day-to-day operations in the health system. Hospital and health-system pharmacies use the FDA's shortage tracking to anticipate which products may be difficult to obtain, to plan their purchasing, and to coordinate with group purchasing organisations and wholesalers. Manufacturers and distributors watch the same data to understand where supply pressure is concentrated. For all of these audiences, the value of a current-shortage index is speed: being able to see, in one place, which products the FDA currently records as in short supply, by whom they are reported, and when each entry was last updated.

This page provides exactly that index and nothing more. It reports the regulatory supply signal — product, company, status and dates — and links to the authoritative FDA record for each entry. It deliberately stops short of any clinical content. It does not say how important a product is, does not suggest what might be used instead, and does not advise any course of action, because those are professional decisions that depend on the full clinical picture and belong with qualified practitioners. The site's role is to help you find and date the official record quickly, then hand you to the regulator's copy.

What each current-shortage record contains

Each record page for a current shortage presents the same regulatory fields as the rest of the shortages section: the generic and brand names where available, the reporting company, the normalised status, the affected presentation, the FDA's availability text as a data field, and the initial-posting and last-updated dates. Because these entries are active, the last-updated date is especially worth attention — it indicates how recently the FDA's record was touched, which is your best on-page cue to how current the information is before you confirm it at the source. For the definitions of these fields and statuses, see the regulatory intelligence glossary, and for the data lineage see the methodology and FDA data sources pages.

Related views

For the full explanation of how shortages are tracked and what each status means, return to the drug shortages hub. The regulatory intelligence glossary defines the terminology, and the methodology and FDA data sources pages describe where the data comes from and its limitations.